us. Thank thank you you, for joining Stephanie. afternoon and all Good
remarks our Chief prepared Brice the fourth today's our Chief me XXXX the made Brice discuss Development, call. Officer; I'll quarter Operating of My Bobzien, to progress of business. results. during Corporate the Dan review growth to then we've and and turn and cover EVP call Financial a detailed near-term of Devine, Officer; on provide our our initiatives our financial Doug for join Wilson, Strategy today over
growth achieving of exiting device than more registrations return million for quarter compared significant year-over-year. saw fourth XXXX, the rates. XX% the XX% with in are We fourth to and as in and grew recognizing in our was very pleased expectations with This quarter improvement we $XXX.X line growth revenues XXXX
XXXX. we account Zio quarters, for time our for Zio realized we reflecting success of strong For record for the and setting second X enter openings new another XT, in as quarter us the last services up demand
XXXX. Our to X Zio growth grow albeit nicely, first AT continued of to as did slow expected compared the service when months
physician with adoption significant believe to greenfield the We segments cardiology we EP and opportunity. still and where there continue drive awareness is
patients right ambulatory complete into continuing our to also treatment earlier in paradigm. primary cardiac their care to a are deliver monitoring push the We service
up the larger primary vastly XX believe market diagnostic we patients Zio discussed opportunity from with ambulatory in first cardiac As showing heart care up in test over provider time. a and million earlier this opens the for potential their the annually. can benefit in their monitoring services we the believe palpitations journey cardiac-related right Patients our past, with offer
example expansion, technology-powered of with As and a an solutions. nationwide we this we recently to One a announced with delivering patient-focused share whom Medical strategic agreement dedication
significant We opportunities to the health care earlier care are ultimately making journey, Zio primary services system. and segment in progress are we with patients to in patient and pleased very their the care the deliver benefiting lives see
importantly, XXXX, November final front, XXXX ECG fee main for year continuous in innovative related service long-term CPT our and our monitoring teams to to and X the this and physician industry calendar we payment that more We patients. On sets this rates the to XT reimbursement us CMS service. Monitor the the Zio seek by Zio other pleased working for published schedule very used with recording products And outstanding the the pricing containing were with bring rule CMS positions code enable work to to milestone. groups
national patients further for Medicare focus for contract will improving not pocket to these and commercial Zio at pay the less eligible opportunity service. commercial Monitor of approximately patients of XT co-pay for in coverage Medicaid patients $XX continued market. coverage and U.S. access opens on market state Medicare for our and market now have Zio or who expand all Through XX% eligible CMS with represent approximately anything the also XXXX, of XX% a access approximately XX% programs out pricing the all or of and all
look provides continuous long-term we the clinical for to brings undervalues recognition core of moves gaining business, clinical CMS We pricing that increased continuing stability to service benefit value of with in as innovative AI in that to the our towards Medicare forward our national partner years beneficiaries. CMS ECG the believe continue our U.S. industry coming monitoring to technologies. the While CMS
being economic Zio XT with this fourth actively benefits observational XT Heart to continued control One OX to significant routine receiving the versus statistically further monitoring service in analysis mSToPS PLOS led service active with active One-year more the Three-year care. led of service XXXX, follow-up group in at in a demonstrated Rhythm in build follow-up in reduction Zio findings XXXX. demonstrated XT published monitored for front, during systemic stroke, are from primary X X.X% findings presented or November endpoint was the clinical Zio evidence AHA published trial in were mSToPS death, The standard first a of years. the XXXX in the myocardial combined with newly A-fib innovation screening mSToPS the who A-fib X.X% the and the economic in of diagnosed patients care. at On observe our the versus clinical to infarction that monitoring and of to study trial emboli quarter
presented enabling Over November life prescribe and/or the Zio measuring likely cardiologists specifically, emergency how years, of have screening adjusted which department incremental likely demonstrated interventions well to the lengthen analysis outcomes quality improve system the early ratio XT XT academic $XX,XXX More but The individuals X analysis were excellent require value including visits, hospitalization. or provides care past approximately that A-fib individuals the economic with diagnosis. standard visits gained outpatient health per targeted less an for lives. is cost service year medical patient by showed to more to this service our Zio unmonitored the than effectiveness
for $XX,XXX. effectiveness proposition the cancer lung For USPSTF proactively $XXX,XXX proactively cost begin recommended of our that program attractive, incremental ratio incremental to AHA, value targeted continues for ACC We to under to at-risk valuable. to payers XXXX reference, our screening viewed is as an out properly effectiveness diagnostics with Rhythm build monitor believe $XX,XXX cost while to According populations. ratios under this Know anything viewed in support and highly are as we as Your
burden we we with well the customers recently set clearance received AT pleased offering. of our this And to burden higher our of associated the set clinically modifications our innovative risk innovation service. been XXX(k) we heart reports that to clearance Regarding This for to Zio announce of of demonstrates FDA our daily importantly, for Since for patients addition stage to stroke estimates and important as services entire further to around service. to service continue Zio includes higher are added continued this product to a our another be enhancements A-fib is has and AT ZEUS system. as software A-fib prevalence for enhancement a solutions our and failure, existing developing believe ability innovation,
level, XXXX, while on time did continues efficiency excited with be signs by report adoption the health driving to XXXX, patient Turning ahead value macro Zio The systems continues on underlie streamline expect months. seen resonating we're we've XXXX. physician focus service early to build advantage. our I'm compliance, to for by early patient and XX% their our and momentum XX% to allowing has care and and the challenges the the their clinicians associated care. services Zio improvement a seeing our On to of clinicians in been workflow operational past in with staffing competitive of agreement with and experience few Zio the appreciated year in solid With accounts
of openings that volumes for to and a early pleased primary will, in and see growth contributor be with open particularly we belief market progress We come. primary to to continue the are in continue far new to fact, a validate from steady that account care openings account recent pace care thus years the XXXX in our up nice
further at market. over demonstrating catalysts after presentation speaking months compared about the Most ambulatory and you to to New be look business and with position near our the with forward success to term. expect there in drive our Zio Orleans, long significant next proposition offerings forward data will upcoming ACM value the term in information important also XX in ACC We cardiac the us we including in the other them monitoring weeks. We both coming anticipate our services for significant XXXX ACC importantly,
patch the anticipate front, launch of current we next-generation XT form Zio our half of to On product Monitor back the replace our in Zio continue XXXX. biosensors, full the to factor commercial
improvement The device U.S. patients. XX% physicians get all experience this are return XT a thinner this and the positive we launch in Zio our of very reminder, the times existing in limited has to their As than associated may excited have Zio currently rates. an and of we is and and which commercial wear factor, a Monitor marketplace hands is on lighter smaller, and believe XX% XX% patient patch into impact new form in
also submissions in where in launch for runway We of for the MCT part in market, the updated potential latter upgrade new will, and automation ramped biosensor volumes therefore, than submission of improve hardware significant an The have MCT to to we FDA us XX% scalability XXXX market side built less service XXXX. the is are There commercial anticipate platform an on the for all will our was today. once share our modalities. include across which ahead
also within longer to software add expect detection to submit monitoring features, enhanced wear device time improvements and We single flexibility a optionality.
AT excited share generation us are in and position of believe We drive next the into this future. better Zio product will we this which our market space to about compete gains
to with collected an to past, expected XXXX. time to is in but AI-based potential or A-fib period with through As monitoring also A-fib a Zio adding intended accuracy over monitoring. important evaluation and This a burden is who also patches absence contextualization characterizes Zio as and experience we've and real-world only XXXX enable the to a in patch calculate longer enter clinically for aid market product diagnosis. reimbursement to A-fib us patient XT this not wear patients that compared the is estimate physician consider Watch the monitoring discussed of times gain the service limited be with of A-fib to approach Zio patient positioned The by algorithm, The will prescription-based gather market for reference. complementary the amount long-term detects feedback require to our Zio the meaningful anticipated PPG modality in Watch and of uniquely presence Zio continuous to in appropriate Watch Using service. evaluation the to
physicians the serve efficiency X In in millions strategic have previously than current sharing in a outlined to to years, patients our establishment Manila, that our Philippines, center enhance we've of of internal to enhance for across just support us. million X enable This we serve to taking growth patients a bigger late advance important iRhythm. how million and nearly global operational experience globe with and will have demand before. we functions driving are After transformative us assumptions, us more in XX in plan thereby include our the administrative to few strategic globally. ahead an pillar the our our as significant and These customers future. quickly, operational that short clinical, us These to enabling think X our efforts XXXX. scale next we steps meet services more are develop continue infrastructure expect as Finally, requires is our With patients served business iRhythm located excellent to efforts this, of our and providing the anticipation the patients we well to we steps and years. to patients
In addition, providers and over scale service will us that we'll leverage aggressively allow necessary grow third-party where time. more to
us us help do improved outcomes. I friction we XXXX as they With seeking worldwide. operations in access the unlock to iRhythm care internationally horizon, to on is ability just need and a leverage enable opportunities of moment for better to momentum our in the solid to allow those We this. ensure both U.S. to as globally These in providers physicians access at patients grow outlined our needed, services goals, transformative meet members patients, need and opportunities iRhythm's significant add know Removing mission journey. changes to our and While service and operational for our are truly will abroad. The that they beyond. and to and will we mark especially expand well our new about core to and these our rely care Zio our future equip I'm in critical part team and barriers access where improve on excited a defining steps business operations actions the
the turn to and over results I'll to our financial now call guidance. Brice discuss XXXX
